Literature DB >> 2117218

Subclinical alveolitis in immunologic systemic disorders.

B Wallaert1.   

Abstract

Subclinical alveolitis is a frequent finding in immunologic systemic disorders. However the significance of subclinical alveolar inflammation does not seem to be univocal and varies according to the disease. The fact that pulmonary involvement is rare during the course of extrathoracic granulomatosis like Crohn's disease or primary cirrhosis and that subclinical alveolitis is frequent suggests that alveolar inflammation may be the expression in the lung of a systemic immune disorder. In contrast subclinical alveolitis in collagen-vascular diseases, particularly progressive systemic sclerosis, is frequently associated with abnormalities of lung parenchyma as assessed by CT scan supporting the hypothesis that subclinical alveolitis is associated with development of ILD. Close follow-up of these patients is needed to better determine whether subclinical alveolitis precedes ILD and whether early detection of subclinical alveolitis in immunologic systemic disorders may identify those patients that are at risk for the development of ILD in the future.

Entities:  

Mesh:

Year:  1990        PMID: 2117218     DOI: 10.1007/bf02718235

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  47 in total

1.  Lower respiratory tract abnormalities in rheumatoid interstitial lung disease. Potential role of neutrophils in lung injury.

Authors:  J G Garcia; H L James; S Zinkgraf; M B Perlman; B A Keogh
Journal:  Am Rev Respir Dis       Date:  1987-10

2.  Quantitation of inflammatory activity in interstitial pneumonitis by bronchofiberscopic pulmonary lavage.

Authors:  G S Davis; A R Brody; J N Landis; W G Graham; J E Craighead; G M Green
Journal:  Chest       Date:  1976-02       Impact factor: 9.410

3.  Pulmonary permeability in coeliac disease and inflammatory bowel disease.

Authors:  D A Robertson; N Taylor; H Sidhu; A Britten; C L Smith; G Holdstock
Journal:  Digestion       Date:  1989       Impact factor: 3.216

4.  Lymphocyte subpopulations in bronchoalveolar lavage fluid in asbestos workers.

Authors:  A R Gellert; M G Macey; S Uthayakumar; A C Newland; R M Rudd
Journal:  Am Rev Respir Dis       Date:  1985-10

5.  [Latent chronic alveolitis in collagen diseases. Diagnosis by bronchoalveolar lavage and its significance].

Authors:  C Voisin; B Wallaert; B Devulder; P Y Hatron
Journal:  Bull Acad Natl Med       Date:  1985-12       Impact factor: 0.144

6.  Activated alveolar macrophage and lymphocyte alveolitis in extrathoracic sarcoidosis without radiological mediastinopulmonary involvement.

Authors:  B Wallaert; P Ramon; E C Fournier; L Prin; A B Tonnel; C Voisin
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

7.  Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis.

Authors:  G W Hunninghake; J E Gadek; T J Lawley; R G Crystal
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

8.  Role of inflammation in the lung disease of systemic sclerosis: comparison with idiopathic pulmonary fibrosis.

Authors:  G R Owens; I L Paradis; S Gryzan; T A Medsger; W P Follansbee; H A Klein; J H Dauber
Journal:  J Lab Clin Med       Date:  1986-03

Review 9.  Bronchoalveolar lavage: role in the pathogenesis, diagnosis, and management of interstitial lung disease.

Authors:  R P Daniele; J A Elias; P E Epstein; M D Rossman
Journal:  Ann Intern Med       Date:  1985-01       Impact factor: 25.391

10.  From subclinical alveolitis to granulomatosis. Sequential evaluation of pulmonary involvement in extrathoracic sarcoidosis.

Authors:  M Dugas; B Wallaert; A B Tonnel; C Voisin
Journal:  Chest       Date:  1989-10       Impact factor: 9.410

View more
  5 in total

1.  Intravenous immune globulin in lysinuric protein intolerance.

Authors:  C Dionisi-Vici; L De Felice; M el Hachem; S Bottero; C Rizzo; A Paoloni; B Goffredo; G Sabetta; M Caniglia
Journal:  J Inherit Metab Dis       Date:  1998-04       Impact factor: 4.982

2.  Detection of anti-cytokeratin 8 antibody in the serum of patients with cryptogenic fibrosing alveolitis and pulmonary fibrosis associated with collagen vascular disorders.

Authors:  N Dobashi; J Fujita; Y Ohtsuki; I Yamadori; T Yoshinouchi; T Kamei; M Tokuda; S Hojo; H Okada; J Takahara
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

Review 3.  Pulmonary involvement and allergic disorders in inflammatory bowel disease.

Authors:  Nikolaos E Tzanakis; Ioanna G Tsiligianni; Nikolaos M Siafakas
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

4.  Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis.

Authors:  W A Wallace; S N Roberts; H Caldwell; E Thornton; A P Greening; D Lamb; S E Howie
Journal:  Thorax       Date:  1994-03       Impact factor: 9.139

5.  Pulmonary function in patients with ulcerative colitis and its relationship with disease severity.

Authors:  Ajesh Goyal; Uday C Ghoshal; Alok Nath; Shikha Jindal; Samir Mohindra
Journal:  JGH Open       Date:  2017-09-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.